Startup Dossier
InBrain Pharma
InBrain Pharma is a neurotech biotech startup pioneering circadian intracerebroventricular (i.c.v.) brain infusion therapies, specifically for advanced Parkinson’s disease. The company offers the world’s first personalized cerebral dopamine supplementation (A-dopamine), aiming to restore motor function by compensating for dopamine deficiency directly in the brain.
About
InBrain Pharma is a neurotech biotech startup pioneering circadian intracerebroventricular (i.c.v.) brain infusion therapies, specifically for advanced Parkinson’s disease. The company offers the world’s first personalized cerebral dopamine supplementation (A-dopamine), aiming to restore motor function by compensating for dopamine deficiency directly in the brain.
Structural DNA
Legal Name
InBrain Pharma
SIREN
840545123